These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 12605576)
1. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study. Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576 [TBL] [Abstract][Full Text] [Related]
2. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689 [TBL] [Abstract][Full Text] [Related]
3. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Burgos R; Mateo C; Cantón A; Hernández C; Mesa J; Simó R Diabetes Care; 2000 Jan; 23(1):80-3. PubMed ID: 10857973 [TBL] [Abstract][Full Text] [Related]
4. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy. Spranger J; Bühnen J; Jansen V; Krieg M; Meyer-Schwickerath R; Blum WF; Schatz H; Pfeiffer AF Horm Metab Res; 2000 May; 32(5):196-200. PubMed ID: 10871161 [TBL] [Abstract][Full Text] [Related]
5. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation? Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279 [TBL] [Abstract][Full Text] [Related]
6. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249 [TBL] [Abstract][Full Text] [Related]
7. Vitreal insulin-like growth factor binding proteins (IGFBPs) are increased in human and animal diabetics. Waldbillig RJ; Jones BE; Schoen TJ; Moshayedi P; Heidersbach S; Bitar MS; van Kuijk FJ; de Juan E; Kador P; Chader GJ Curr Eye Res; 1994 Jul; 13(7):539-46. PubMed ID: 7523030 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factors and their binding proteins in children with IDDM. Wacharasindhu S; Srivuthana S; Aroonparkmongkol S J Med Assoc Thai; 2002 Jan; 85(1):41-52. PubMed ID: 12075719 [TBL] [Abstract][Full Text] [Related]
9. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer. Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis. Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339 [TBL] [Abstract][Full Text] [Related]
11. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins. Feldmann B; Jehle PM; Mohan S; Lang GE; Lang GK; Brueckel J; Boehm BO Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593 [TBL] [Abstract][Full Text] [Related]
12. Age-related serum levels of insulin-like growth factor-I, -II and IGF-binding protein-3 following myocardial infarction. Reeves I; Abribat T; Laramee P; Jasmin G; Brazeau P Growth Horm IGF Res; 2000 Apr; 10(2):78-84. PubMed ID: 10931745 [TBL] [Abstract][Full Text] [Related]
13. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy. Wang X; Wang G; Wang Y Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381 [TBL] [Abstract][Full Text] [Related]
14. [Significance and detection of insulin-like growth factor I in vitreous with proliferative retinal diseases by radioimmunoassay]. Cao J; Wu L; Zhang H Zhonghua Yan Ke Za Zhi; 1995 Mar; 31(2):122-5. PubMed ID: 7656720 [TBL] [Abstract][Full Text] [Related]
15. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus. Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141 [TBL] [Abstract][Full Text] [Related]
16. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment. Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949 [TBL] [Abstract][Full Text] [Related]
17. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications. Capoluongo E; Pitocco D; Santonocito C; Concolino P; Santini SA; Manto A; Lulli P; Ghirlanda G; Zuppi C; Ameglio F Eur Cytokine Netw; 2006 Sep; 17(3):167-74. PubMed ID: 17194636 [TBL] [Abstract][Full Text] [Related]
18. The insulin-like growth factor system and Type 1 diabetic retinopathy during pregnancy. Loukovaara S; Immonen IJ; Koistinen R; Rutanen EM; Hiilesmaa V; Loukovaara M; Kaaja RJ J Diabetes Complications; 2005; 19(5):297-304. PubMed ID: 16112506 [TBL] [Abstract][Full Text] [Related]
19. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Simó R; Lecube A; Segura RM; García Arumí J; Hernández C Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249 [TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression. Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]